France· FR:69389575
PLERIXAFOR ARROW 20 mg/mL, solution injectable
A plerixafor product containing plérixafor, registered in France by EUGIA PHARMA (MALTA) (MALTE). The same ATC class is registered in 17 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Plerixafor is registered in 17 of 19 countries.
Countries holding a registration under ATC L03AX16 (plerixafor), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 9 of them publish a price we can compare per daily dose
Plerixafor · ATC L03AX16
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- PLÉRIXAFOR
- Manufacturer
- EUGIA PHARMA (MALTA) (MALTE)
- Country
- France (FR)
- ATC code
- L03AX16
- ATC class
- Plerixafor
- Defined daily dose
- 16.8 mg, P
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009302689711 flacon en verre de 1,2 mL
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Plerixafor in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesMozobilSanofi-Aventis U.S. LLC
- NetherlandsMozobil 20 mg/ml, oplossing voor injectieGenzyme Europe BV
- IrelandMozobil 20 mg/ml Solution for injectionGenzyme Europe B.V.
- GermanyPlerixafor AmaroxAmarox Pharma Gmbh
- SpainMOZOBIL 20 mg/ml SOLUCION INYECTABLESanofi B.V.
- United KingdomMozobil 24mg/1.2ml solution for injection vialsSanofi
- FinlandMozobilSanofi B.V.
- SwedenMozobil 20 mg/ml Injektionsvätska, lösningSanofi B.V.
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Plerixafor Stada, Plerixafor Teva
- Bulgaria · Plerixafor Msn
- Czechia · Pleforbil, Plerixafor Msn
- Germany · Plerixafor Amarox, Plerixafor Puren
- Denmark · Plerixafor Seacross, Plerixafor Teva
- Estonia · Plerixafor Auxilia
- Spain · Plerixafor Eugia, Plerixafor Glenmark
- Finland · Plerixafor Seacross, Plerixafor Viatris
- United Kingdom (Northern Ireland) · Plerixafor Amarox Limited, Plerixafor Eugia (Uk)
- Croatia · Pleriksafor Msn, Pleriksafor Onkogen
- Hungary · Plerixafor Msn, Plerixafor Onkogen
- Ireland · Plerixafor Msn Labs Europe, Plerixafor Seacross
- Iceland · Mozobil, Plerixafor Accord
- Italy · Plerixafor Aurobindo, Plerixafor Eg
- Liechtenstein · Mozobil, Plerixafor Accord
- Lithuania · Plerixafor Auxilia
- Netherlands · Plerixafor Amarox, Plerixafor Sandoz
- Norway · Mozobil, Plerixafor Accord
- Poland · Plerixafor Biofar, Plerixafor Msn
- Portugal · Plerixafor Eugia, Plerixafor Mylan
- Romania · Plerixafor Msn Labs Europe
- Sweden · Plerixafor Seacross, Plerixafor Teva
- Slovenia · Pleriksafor Onkogen, Pleriksafor Teva
- Slovakia · Plerixafor Msn, Plerixafor Onkogen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d9ca5ff6-03a2-4ad2-b27a-b15672c3320b GET /v1/drugs/d9ca5ff6-03a2-4ad2-b27a-b15672c3320b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69389575",
"date_amm": "2023-01-30",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "PLÉRIXAFOR",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "sous-cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about plerixafor.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.